MHRA Public Assessment Report – Chloramphenicol Eye Drops Containing Borax and Boric Acid Buffers in Children Under 2 Years MHRA Public Assessment Report – Chloramphenicol Eye Drops Containing Borax and Boric Acid Buffers in Children Under 2 Years MHRA... MHRA Public Assessment Report – Chloramphenicol Eye Drops Containing Borax and Boric Acid Buffers in Children Under 2 Years
MHRA Webinar – Medicines Supply for Northern Ireland MHRA Webinar – Medicines Supply for Northern Ireland Date/Time: Wednesday 2 February 2022, 10:00-11:45 and Thursday 3 February 2022, 14:00-15:45The... MHRA Webinar – Medicines Supply for Northern Ireland
MHRA Consultation on Proposals for Legislative Changes for Clinical Trials MHRA Consultation on Proposals for Legislative Changes for Clinical Trials MHRA has launched a consultation on a set of proposals... MHRA Consultation on Proposals for Legislative Changes for Clinical Trials
MHRA Publishes Marketing Authorisations Granted in December 2021 MHRA’s list of marketing authorisations granted in December 2021 MHRA granted five OTC licences in December 2021. Details of these... MHRA Publishes Marketing Authorisations Granted in December 2021
EMA Public Consultation on “Guidance on the procedural aspects for the consultation to the European Medicines Agency by a notified body on companion diagnostics” and EMA Guidance on Companion Diagnostics Consultation Procedure Published EMA Public Consultation on ‘Guidance on the procedural aspects for the consultation to the European Medicines Agency by a notified... EMA Public Consultation on “Guidance on the procedural aspects for the consultation to the European Medicines Agency by a notified body on companion diagnostics” and EMA Guidance on Companion Diagnostics Consultation Procedure Published
Practical Guidance for Procedures Related to EU Exit for Medicinal Products for Human Use Approved via MRP/DCP – CMDh Guidance Updated Practical Guidance for Procedures Related to EU Exit for Medicinal Products for Human Use Approved via MRP/DCP – CMDh Guidance... Practical Guidance for Procedures Related to EU Exit for Medicinal Products for Human Use Approved via MRP/DCP – CMDh Guidance Updated
CMDh December 2021 Meeting – Report CMDh December 2021 Meeting – Report The Co-ordination group for Mutual recognition and Decentralised procedures – human (CMDh) has published... CMDh December 2021 Meeting – Report
MHRA – December 2021 Licensing Time-based Performance Measures Published MHRA – December 2021 Licensing Time-based Performance Measures Published MHRA publish data on the expected time taken to process and... MHRA – December 2021 Licensing Time-based Performance Measures Published
Importing Medicines into Northern Ireland – MHRA Guidance Updated Importing Medicines into Northern Ireland – MHRA Guidance Updated The MHRA guidance ‘Importing medicines into Northern Ireland’ has been updated.The... Importing Medicines into Northern Ireland – MHRA Guidance Updated
MHRA Business Impact Target – NQRP Summary for 2020/21 MHRA Business Impact Target – NQRP Summary for 2020/21 The business impact target (BIT) is a cross-government target for the... MHRA Business Impact Target – NQRP Summary for 2020/21
EMA – Public Consultation on the Guideline on the Acceptability of Names for Human Medicinal Products Processed Through the Centralised Procedure EMA – Public Consultation on the Guideline on the Acceptability of Names for Human Medicinal Products Processed Through the Centralised... EMA – Public Consultation on the Guideline on the Acceptability of Names for Human Medicinal Products Processed Through the Centralised Procedure
Publication of Joint HMA-EMA Data Standardisation Strategy Publication of Joint HMA-EMA Data Standardisation Strategy The joint HMA-EMA Data Standardisation Strategy (DSS) has been published... Publication of Joint HMA-EMA Data Standardisation Strategy
